Is there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?

Simple item page
dc.contributor.authorİnanç, Nevsun
dc.contributor.authorÖzen, Gülşen
dc.contributor.authorYalçınkaya, Yasemin
dc.contributor.authorKoca, Süleyman Serdar
dc.contributor.authorCan, Gerçek
dc.contributor.authorKarataş, Ahmet
dc.contributor.authorYazıcı, Ayten
dc.contributor.authorCefle, Ayşe
dc.contributor.authorTufan, Abdurrahman
dc.contributor.authorAkar, Servet
dc.contributor.authorŞenel, Soner
dc.contributor.authorÖz, Burak
dc.contributor.authorAkkoç, Nurullah
dc.contributor.authorÖnen, Fatoş
dc.contributor.buuauthorDalkılıç, Ediz
dc.contributor.buuauthorPehlivan, Yavuz
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Romatoloji Bilim Dalı.tr_TR
dc.contributor.researcheridCMF-4757-2022tr_TR
dc.contributor.researcheridFQP-0451-2022tr_TR
dc.date.accessioned2024-01-10T12:23:14Z
dc.date.available2024-01-10T12:23:14Z
dc.date.issued2018-06
dc.descriptionBu çalışma, 13-16, Haziran 2018 tarihlerinde Amsterdam[Hollanda]’da düzenlenen Congress of the European-League-Against-Rheumatism (EULAR) Kongresi‘nde bildiri olarak sunulmuştur.tr_TR
dc.description.sponsorshipEuropean League Against Rheumatismen_US
dc.identifier.citationİnanç, N. vd. (2018). ''Is there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?''. Annals of the Rheumatic Diseases, 77(Supplement 2), 611-612.en_US
dc.identifier.doihttps://doi.org/10.1136/annrheumdis-2018-eular.5662
dc.identifier.eissn1468-2060
dc.identifier.endpage612tr_TR
dc.identifier.issn0003-4967
dc.identifier.issueSupplement 2en_US
dc.identifier.startpage611tr_TR
dc.identifier.urihttps://ard.bmj.com/content/77/Suppl_2/611.2
dc.identifier.urihttps://hdl.handle.net/11452/38944
dc.identifier.volume77tr_TR
dc.identifier.wos000444351001597tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.wosSCIEen_US
dc.indexed.wosCPCISen_US
dc.language.isoenen_US
dc.publisherBMJ Publishing Groupen_US
dc.relation.collaborationYurt içitr_TR
dc.relation.journalAnnals of the Rheumatic Diseasesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectRheumatologyen_US
dc.subject.wosRheumatologyen_US
dc.titleIs there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?en_US
dc.typeArticleen_US
dc.wos.quartileQ1 (Rheumatology)en_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Dalkılıç_vd_2018.pdf
Size:
577.59 KB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science